المؤلفون: Gail V. Matthews, Sanjay Bhagani, Marc Van der Valk, Juergen Rockstroh, Jordan J. Feld, Andri Rauch, Christine Thurnheer, Julie Bruneau, Arthur Kim, Margaret Hellard, David Shaw, Ed Gane, Mark Nelson, Patrick Ingiliz, Tanya L. Applegate, Jason Grebely, Phillipa Marks, Marianne Martinello, Kathy Petoumenos, Gregory J. Dore, Marc van der Valk, Greg Dore, Pip Marks, Gail Matthews, Tanya Applegate, Jordan Feld, Jürgen Rockstroh, Sophia Amjad, Elise Tu, Mahshid Tamaddoni, Maria Christine Thurnheer, Yvonne Gilleece, Chris Fraser, Alberto Moriggia, Thomas Lutz, Juhi Moon, Phillip Read, Arthur Y. Kim, Andrew Ustianowski, Christiane Cordes, Joe Sasadeusz, Mark Hull, Dominique Braun

المساهمون: Infectious diseases, AII - Infectious diseases, APH - Digital Health, APH - Personalized Medicine, APH - Global Health

المصدر: Matthews, Gail V; Bhagani, Sanjay; Van der Valk, Marc; Rockstroh, Juergen; Feld, Jordan J; Rauch, Andri; Thurnheer, Christine; Bruneau, Julie; Kim, Arthur; Hellard, Margaret; Shaw, David; Gane, Ed; Nelson, Mark; Ingiliz, Patrick; Applegate, Tanya L; Grebely, Jason; Marks, Phillipa; Martinello, Marianne; Petoumenos, Kathy; Dore, Gregory J; ... (2021). Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection. Journal of hepatology, 75(4), pp. 829-839. Elsevier 10.1016/j.jhep.2021.04.056 <http://dx.doi.org/10.1016/j.jhep.2021.04.056>
J Hepatol
Journal of hepatology, 75(4), 829-839. Elsevier

مصطلحات موضوعية: 0301 basic medicine, Male, Time Factors, Sofosbuvir, Human immunodeficiency virus (HIV), recently acquired, medicine.disease_cause, Virological response, 0302 clinical medicine, Germany, Clinical endpoint, Short course, 610 Medicine & health, Netherlands, education.field_of_study, treatment, short duration, acute, Hepatitis C, Middle Aged, Drug Combinations, Treatment Outcome, HCV, 030211 gastroenterology & hepatology, Female, Switzerland, medicine.drug, Adult, medicine.medical_specialty, Canada, Population, Sofosbuvir/velpatasvir, Antiviral Agents, Heterocyclic Compounds, 4 or More Rings, Article, 03 medical and health sciences, Internal medicine, medicine, Humans, education, direct-acting antivirals, Hepatology, business.industry, Australia, medicine.disease, United Kingdom, 030104 developmental biology, Carbamates, business, New Zealand

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56cb0f6e8b73a263af7310a4cfd284e8
https://boris.unibe.ch/156581/1/1-s2.0-S0168827821003366-main.pdf

المؤلفون: Behzad Hajarizadeh, Jason Grebely, Marianne Byrne, Pip Marks, Janaki Amin, Hamish McManus, Tony Butler, Evan B Cunningham, Peter Vickerman, Natasha K Martin, John G McHutchison, Diana M Brainard, Carla Treloar, Georgina M Chambers, Luke Grant, Colette Mcgrath, Andrew R Lloyd, Gregory J Dore, Stuart Loveday, Gregory Dore, Andrew Lloyd, Georgina Chambers, Mahshid Tamaddoni, Stephanie Obeid, Gerard Estivill Mercade, Maria Martinez, Roy Donnelly, Colette McGrath, Julia Bowman, Lee Trevethan, Katerina Lagios, Terry Murrell, Nicky Bath, Victor Tawil, Annabelle Stevens, Libby Topp, Alison Churchill, Kate Pinnock, Natasha Martin, Steven Drew, Mary Harrod, Angela Smith, Ronella Williams, Brigid Cooper, Kelly Somes, Carina Burns, Anoop Kaur, Camilla Lobo, Karen Conroy, Luke McCredie, Carolyn Café, Jodie Anlezark, William Rawlinson, Malinna Yeang, Matthew Wynn, Christiana Willenborg

المصدر: et al. 2021, ' Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C) : a prospective cohort study ', The Lancet Gastroenterology and Hepatology, vol. 6, no. 7, pp. 533-546 . https://doi.org/10.1016/S2468-1253(21)00077-7

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Sofosbuvir, Rate ratio, Antiviral Agents, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Prospective Studies, Prospective cohort study, Hepatology, business.industry, Incidence (epidemiology), Incidence, Prisoners, Hazard ratio, Gastroenterology, Australia, Hepatitis C, Hepatitis C, Chronic, medicine.disease, Treatment as prevention, 030220 oncology & carcinogenesis, Prisons, Cohort, 030211 gastroenterology & hepatology, Female, New South Wales, business, medicine.drug, Follow-Up Studies

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5201969650c3e85e7263edf82cdc7d8f
https://hdl.handle.net/1983/ee5a5ce6-d89a-4c7f-b11f-19a508ee17ce